BioSpace News Archive

Press Releases

TNF Pharmaceuticals Announces Strategic Equity Investment Priced at a Premium to Market

October 2, 2024
·
6 min read
Press Releases

Immix Biopharma Advances CAR-T NXC-201 to Expansion Cohort Dose Level in U.S. AL Amyloidosis Trial NEXICART-2

October 2, 2024
·
7 min read
Press Releases

Results from a Phase I clinical trial of a dendritic cell targeting prophylactic HIV vaccine published in the Journal eClinical Medicine

October 2, 2024
·
7 min read
Drug Development

Kineta Announces the Extension of the TuHURA Biosciences Exclusivity and Right of First Offer Agreement for KVA12123, Kineta’s VISTA blocking antibody Currently in Phase 1

October 2, 2024
·
7 min read
Business

Venus Concept to Release Third Quarter of Fiscal Year 2024 Financial Results on November 13, 2024

October 2, 2024
·
1 min read
Press Releases

Altimmune to Participate in the H.C. Wainwright 8th Annual MASH Virtual Conference

October 2, 2024
·
1 min read
Press Releases

Cognition Therapeutics Supports Lewy Body Dementia Awareness Month and the Need for Improved Treatments for the Second Most Common Dementia

October 2, 2024
·
7 min read
Press Releases

Intellia Therapeutics to Present New Clinical Data from the Phase 1 Study of nexiguran ziclumeran (nex-z) for the Treatment of Transthyretin (ATTR) Amyloidosis at the 2024 AHA Scientific Sessions

October 2, 2024
·
6 min read
Press Releases

Palatin Reports Fourth Quarter and Fiscal Year Ended 2024 Financial Results, Provides Update on Clinical Programs, Strategic Priorities, and Anticipated Milestones

October 2, 2024
·
17 min read
Press Releases

Mainz Biomed Publishes CEO Statement; CEO Guido Baechler Eyes Major Growth and U.S. FDA Trials in 2025

October 2, 2024
·
8 min read